Allianz Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.29M | Sell |
4,400
-2,300
| -34% | -$756K | ﹤0.01% | 1668 |
|
|
2025
Q4 | $2.35M | Buy |
6,700
+1,900
| +40% | +$642K | ﹤0.01% | 1480 |
|
|
2025
Q3 | $1.55M | Sell |
4,800
-2,000
| -29% | -$622K | ﹤0.01% | 1592 |
|
|
2025
Q2 | $2.64M | Buy |
6,800
+4,200
| +162% | +$1.69M | ﹤0.01% | 1378 |
|
|
2025
Q1 | $1.13M | Buy |
2,600
+200
| +8% | +$80.3K | ﹤0.01% | 1652 |
|
|
2024
Q4 | $885K | Buy |
2,400
+1,800
| +300% | +$753K | ﹤0.01% | 1676 |
|
|
2024
Q3 | $312K | Buy |
600
+400
| +200% | +$214K | ﹤0.01% | 1981 |
|
|
2024
Q2 | $108K | Sell |
200
-800
| -80% | -$423K | ﹤0.01% | 2053 |
|
|
2024
Q1 | $519K | Sell |
1,000
-1,600
| -62% | -$796K | ﹤0.01% | 1613 |
|
|
2023
Q4 | $1.23M | Sell |
2,600
-6,100
| -70% | -$2.82M | ﹤0.01% | 1520 |
|
|
2023
Q3 | $3.79M | Buy |
8,700
+100
| +1% | +$45.4K | 0.01% | 1122 |
|
|
2023
Q2 | $3.82K | Buy |
8,600
+1,700
| +25% | +$784K | ﹤0.01% | 1992 |
|
|
2023
Q1 | $3.17M | Buy |
6,900
+900
| +15% | +$428K | 0.01% | 1172 |
|
|
2022
Q4 | $3.08M | Buy |
6,000
+2,900
| +94% | +$1.47M | 0.01% | 1122 |
|
|
2022
Q3 | $1.41M | Buy |
3,100
+2,300
| +288% | +$1.1M | ﹤0.01% | 1340 |
|
|
2022
Q2 | $386K | Sell |
800
-3,100
| -79% | -$1.53M | ﹤0.01% | 1952 |
|
|
2022
Q1 | $1.92M | Buy |
3,900
+2,300
| +144% | +$1.05M | ﹤0.01% | 1605 |
|
|
2021
Q4 | $742K | Sell |
1,600
-4,300
| -73% | -$1.81M | ﹤0.01% | 2033 |
|
|
2021
Q3 | $2.2M | Buy |
5,900
+3,000
| +103% | +$1.14M | ﹤0.01% | 1626 |
|
|
2021
Q2 | $1.11M | Buy |
+2,900
| New | +$1.11M | ﹤0.01% | 1702 |
|
|
2020
Q3 | – | Sell |
-10,900
| Closed | -$2.87M | – | 2023 |
|
|
2020
Q2 | $2.87M | Sell |
10,900
-2,600
| -19% | -$694K | ﹤0.01% | 1454 |
|
|
2020
Q1 | $3.06M | Sell |
13,500
-23,900
| -64% | -$6.51M | ﹤0.01% | 1372 |
|
|
2019
Q4 | $11.3M | Buy |
37,400
+6,500
| +21% | +$1.79M | 0.01% | 1071 |
|
|
2019
Q3 | $7.42M | Buy |
30,900
+7,600
| +33% | +$2.08M | 0.01% | 1258 |
|
|
2019
Q2 | $6.58M | Buy |
23,300
+13,300
| +133% | +$3.63M | 0.01% | 1372 |
|
|
2019
Q1 | $2.87M | Buy |
10,000
+7,100
| +245% | +$2.05M | ﹤0.01% | 1696 |
|
|
2018
Q4 | $762K | Sell |
2,900
-10,400
| -78% | -$2.86M | ﹤0.01% | 2135 |
|
|
2018
Q3 | $3.65M | Sell |
13,300
-2,200
| -14% | -$571K | ﹤0.01% | 1698 |
|
|
2018
Q2 | $3.69M | Buy |
15,500
+1,100
| +8% | +$255K | ﹤0.01% | 1670 |
|
|
2018
Q1 | $3.16M | Sell |
14,400
-15,600
| -52% | -$3.66M | ﹤0.01% | 1730 |
|
|
2017
Q4 | $6.75M | Sell |
30,000
-32,200
| -52% | -$6.86M | 0.01% | 1495 |
|
|
2017
Q3 | $11.8M | Buy |
62,200
+19,900
| +47% | +$3.79M | 0.01% | 1245 |
|
|
2017
Q2 | $7.96M | Buy |
42,300
+4,400
| +12% | +$791K | 0.01% | 1399 |
|
|
2017
Q1 | $6.27M | Sell |
37,900
-21,100
| -36% | -$3.36M | 0.01% | 1537 |
|
|
2016
Q4 | $8.48M | Buy |
59,000
+22,300
| +61% | +$2.99M | 0.01% | 1432 |
|
|
2016
Q3 | $4.6M | Buy |
36,700
+13,900
| +61% | +$1.79M | ﹤0.01% | 1651 |
|
|
2016
Q2 | $3M | Buy |
22,800
+200
| +0.9% | +$27.4K | ﹤0.01% | 1742 |
|
|
2016
Q1 | $3.14M | Buy |
22,600
+13,300
| +143% | +$1.78M | ﹤0.01% | 1613 |
|
|
2015
Q4 | $1.3M | Buy |
9,300
+4,500
| +94% | +$620K | ﹤0.01% | 1879 |
|
|
2015
Q3 | $672K | Sell |
4,800
-3,200
| -40% | -$481K | ﹤0.01% | 1971 |
|
|
2015
Q2 | $1.31M | Buy |
8,000
+800
| +11% | +$128K | ﹤0.01% | 1862 |
|
|
2015
Q1 | $1.11M | Sell |
7,200
-3,700
| -34% | -$527K | ﹤0.01% | 1749 |
|
|
2014
Q4 | $1.37M | Buy |
10,900
+6,000
| +122% | +$741K | ﹤0.01% | 1709 |
|
|
2014
Q3 | $586K | Buy |
+4,900
| New | +$562K | ﹤0.01% | 1844 |
|
Other funds holding ELV
VCM
VPM
Allianz Asset Management's ELV Position: Q1 2026 in Review
Allianz Asset Management increased its Elevance Health (ELV) stake by 29% in Q1 2026, buying an estimated $39.7M and bringing the position to 535,894 shares worth $157M. The position accounts for 0.16% of the portfolio, ranked #119.
Allianz Asset Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $548M in Q1 2015. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Allianz Asset Management held 535,894 shares of Elevance Health worth $157M as of Q1 2026.
- Allianz Asset Management bought 120,821 Elevance Health shares in Q1 2026, an estimated $39.7M.
- Elevance Health made up 0.16% of Allianz Asset Management's portfolio in Q1 2026, its #119 holding.
- Allianz Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Elevance Health position peaked at $548M in Q1 2015.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.